Generate Biomedicines, Inc. (GENB) Form 10-K Annual Reports
Generate Biomedicines, Inc. (GENB) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: GENB
CIK: 2100782
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerMichael Donovan
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-09-03 | 2026-09-01 | 4 | 0001193125-26-381875 | View SEC Doc Filr Page |
| 144 | 2026-09-02 | — | 144 Filing | 0001959173-26-006666 | View SEC Doc Filr Page |
| 144 | 2026-09-01 | — | 144 Filing | 0001959173-26-006611 | View SEC Doc Filr Page |
| 8-K | 2026-08-26 | 2026-08-25 | 8-K | 0001193125-26-365556 | View SEC Doc Filr Page |
| 10-Q | 2026-08-06 | 2026-06-30 | 10-Q | 0001193125-26-336437 | View SEC Doc Filr Page |
| 8-K | 2026-08-06 | 2026-08-06 | 8-K | 0001193125-26-336462 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-05-15 | — | SCHEDULE 13G Filing | 0001193125-26-226574 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-05-15 | — | SCHEDULE 13G Filing | 0001193125-26-225441 | View SEC Doc Filr Page |
| 10-Q | 2026-05-07 | 2026-03-31 | 10-Q | 0001193125-26-210059 | View SEC Doc Filr Page |
| 8-K | 2026-05-07 | 2026-05-07 | 8-K | 0001193125-26-209899 | View SEC Doc Filr Page |
| 3 | 2026-03-12 | 2026-03-02 | 3 | 0000950130-26-000106 | View SEC Doc Filr Page |
| 4 | 2026-03-06 | 2026-03-04 | 4 | 0001193125-26-096799 | View SEC Doc Filr Page |
| 4 | 2026-03-02 | 2026-02-26 | 4 | 0001193125-26-085952 | View SEC Doc Filr Page |
| 4 | 2026-03-02 | 2026-02-26 | 4 | 0001193125-26-085939 | View SEC Doc Filr Page |
| 4 | 2026-03-02 | 2026-02-26 | 4 | 0001193125-26-085928 | View SEC Doc Filr Page |
| 4 | 2026-03-02 | 2026-02-26 | 4 | 0001193125-26-085911 | View SEC Doc Filr Page |
| 4 | 2026-03-02 | 2026-02-26 | 4 | 0001193125-26-085910 | View SEC Doc Filr Page |
| 4 | 2026-03-02 | 2026-02-26 | 4 | 0001193125-26-085903 | View SEC Doc Filr Page |
| 4 | 2026-03-02 | 2026-02-26 | 4 | 0001193125-26-085898 | View SEC Doc Filr Page |
| 4 | 2026-03-02 | 2026-02-26 | 4 | 0001193125-26-085888 | View SEC Doc Filr Page |
| 4 | 2026-03-02 | 2026-02-26 | 4 | 0001193125-26-085886 | View SEC Doc Filr Page |
| 4 | 2026-03-02 | 2026-02-26 | 4 | 0001193125-26-085883 | View SEC Doc Filr Page |
| 4 | 2026-03-02 | 2026-02-26 | 4 | 0001193125-26-085881 | View SEC Doc Filr Page |
| 4 | 2026-03-02 | 2026-02-26 | 4 | 0001193125-26-085872 | View SEC Doc Filr Page |
| 4 | 2026-03-02 | 2026-02-26 | 4 | 0001193125-26-085871 | View SEC Doc Filr Page |